Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.
In this video, Jennifer Goldman, PharmD, CDE, BC-ADM FCCP, who is a professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences School of Pharmacy, discusses with Pharmacy Times the importance of remaining on top of the latest data to best service patients with diabetes.
Dr. Goldman discussed managing diabetes with insulin/GLP-1 receptor agonist combinations during a special session held in conjunction with APhA2017.
"There are gaps in education for diabetes management, and not just for pharmacists, but for all health care professionals. If you think about the new medications that have come on the market over the last 10 years, most of the practitioners out in the world did not learn about those in school. So it is up to them to learn after the fact — via continuing education of some kind or CE programs that they might go to. I think it’s critical to show education. We did some testing and questions about asking the audience above their knowledge, and there’s clear knowledge gaps there. We were able to show how effective this was by teaching the issues that they were not familiar with and then asking them again, and showing that they gained that knowledge during that time."